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Abstract Recently a putative mammalian neutral-sphingomye-
linase was cloned [Tomiuk et al. (1998) Proc. Natl. Acad. Sci.
USA 95, 3638^3643; GenBank accession number AJ222801].
We have overexpressed this enzyme in cultured cells and
demonstrate, using four different tagged constructs, that it is
localized at the endoplasmic reticulum and not at the plasma
membrane. This localization precludes a role for enzyme
AJ222801 in the sphingomyelin cycle. Furthermore, a recent
publication demonstrated that this enzyme has lyso-platelet
activating factor (PAF) phospholipase C activity [Sawai et al.
(1999) J. Biol. Chem. 274, 38131^38139]. Together, these data
suggest a role for enzyme AJ222801 in the regulation of PAF
metabolism.
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1. Introduction
Over the past decade, the sphingomyelin (SM) cycle has
received much attention due to its apparent role in a variety
of intracellular signalling pathways, including apoptosis [1]. In
this cycle, SM is hydrolyzed to ceramide either by acid-sphin-
gomyelinase, located in lysosomes, or by neutral-sphingomye-
linase (N-SMase), presumably located at the plasma mem-
brane (PM) [1]. A variety of N-SMase activities have been
reported, and within the past year, the ¢rst two sequences
of putative N-SMases have become available [2,3]. Whereas
one of these puri¢ed proteins appears to play a role as a
regulator in the SM cycle [3], the other appeared inactive in
signal transduction pathways [2], raising concerns about the
validity of the SM cycle in signalling events.
In the current study, we have overexpressed the enzyme
cloned by Tomiuk et al. [2] (GenBank accession number
AJ222801) in a variety of cultured mammalian cells. The pro-
tein was localized in the endoplasmic reticulum (ER), irrespec-
tive of whether it was tagged at the N- or C-terminus, or in
the loop between the putative transmembrane domains. This
localization is inconsistent with enzyme AJ222801 being in-
volved in the SM cycle. However, a recent biochemical study
has demonstrated that the puri¢ed enzyme shows no SMase
activity when overexpressed in cultured cells, but is rather a
lyso-platelet activating factor (lyso-PAF) phospholipase C [4],
and our data are consistent with this suggestion.
2. Materials and methods
An expressed sequence tag (EST) clone with an identical 5P se-
quence to that of Tomiuk et al. [2] was obtained from the American
Tissue Culture Collection (ATCC clone #921318; GenBank accession
number AA028477). Sub-cloning into pCDNA3/BglII/BamHI and re-
peat sequencing of 5P and 3P ends con¢rmed its identity. However, an
in vitro transcription/translation reaction revealed a translated protein
of only 22 kDa. Sequencing of the entire clone revealed a point mu-
tation relative to the originally published sequence, speci¢cally a dele-
tion of C495. This deletion, and the subsequent frame shift, created a
stop codon at nucleotide 571. In order to restore the desired reading
frame, PCR primers overlapping and £anking the mutation site were
designed, containing the missing C495. These primers were used versus
plasmid primers to amplify both segments of the clone. The two PCR
products were then mixed in an equimolar ratio, annealed and ¢lled
in by DNA polymerase. The ¢nal product was digested with KpnI
and HindIII to yield a 187 bp fragment containing the mutated
region, which was ligated back into the original clone. Correction
of the mutation was veri¢ed by both sequencing and in vitro trans-
lation.
The corrected cDNA clone in pcDNA3 was fused in frame with
four di¡erent tag sequences, as follows. C-terminal green £uorescent
protein (GFP) (C-GFP^AJ222801), created by deleting the enzyme’s
stop codon and inserting a GFP coding sequence in BamHI/NotI with
an eight residue linker between the two open reading frames. Hemag-
glutinin (HA) epitope tags (HA^AJ222801) were inserted via encoding
the sequence YPYDVPYA in three separate locations, either N-ter-
minal in BglII (N-HA^AJ222801), C-terminal in BamHI (C-HA^
AJ222801), or inside the open reading frame in PstI at amino acid
residue Ala346 (A346-HA^AJ222801) (see Fig. 1). Full details of the
cloning strategies and the oligonucleotide sequences can be obtained
from mike.fainzilber@weizmann.ac.il.
COS, HEK-293 and NIH-3T3 cells were grown on glass coverslips
in DMEM and 10% fetal calf serum. One day after plating, COS cells
were transfected using DEAE^dextran [5]. Two days after transfec-
tion, cells were ¢xed with 4% formaldehyde (20 min, 37‡C), and in
some cases, subsequently permeabilized using 0.5% Triton X-100 in
phosphate-bu¡ered saline (5 min, room temperature). Transfections of
HEK-293 were performed using calcium phosphate, and NIH-3T3
cells were transfected with the Fugene reagent (Boehringer Mann-
heim) according to the manufacturers’ instructions. The following
antibodies were used for immuno£uorescence localization: anti-HA
(Berkley Antibody Company); anti-p75 (mc192) (Boehringer Mann-
heim), and anti-protein disul¢de isomerase (PDI) (Stressgen Biotech-
nologies Corp.). A rhodamine-conjugated goat anti-mouse antibody
(Jackson Immunoresearch Laboratories) was used for detection. Cells
were examined using a Plan Apochromat 63U/1.4 n.a. objective of a
Zeiss Axiovert 35 microscope equipped with a ¢lter for rhodamine or
FITC (for GFP) £uorescence, and photographed using a Contax
167MT camera and Kodak Tmax p3200 ¢lm.
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3. Results
Original analysis [2] of enzyme AJ222801 by hydropathy
plots suggested that the protein has two adjacent mem-
brane-spanning domains at the C-terminus separated by a
loop of eight amino acid residues, with the catalytic domain
facing the cytosol (Fig. 1). However, analysis of the sequence
by three di¡erent prediction programs suggested the presence
of an additional transmembrane domain (Fig. 1), and more-
over, the previously proposed topology was not favored by
any of the prediction programs. We therefore tagged the en-
zyme at the C-terminus (HA tag and GFP tag), N-terminus
(HA tag), and in the inter-membrane loop (HA tag), in such
a way that at least one of the tags should be exposed on
the membrane surface if the enzyme is located at the PM
(Fig. 1).
C-GFP^AJ222801 (Fig. 2A,B), C-HA^AJ222801 (Fig.
2C,D), and N-HA^AJ222801 (Fig. 2E,F) were all localized
to an intracellular reticular network in COS cells. Likewise,
A346-HA^AJ222801 was detected at a similar location (Fig.
3A,B), although the resolution of the reticular labeling was
lower, probably due to the inaccessibility of the antibody to
the HA epitope. When cells were ¢xed, but not permeabilized,
no labeling with an anti-HA antibody could be detected in
cells transfected with A346-HA^AJ222801 (Fig. 3C,D) or with
either of the other two HA-tagged proteins (not shown).
Thus, irrespective of the position of the tag on the transfected
protein, labeling of the PM was never detected, strongly sug-
gesting that enzyme AJ222801 is an intracellular protein. This
was con¢rmed by co-transfection experiments, in which COS
cells were transfected with the p75 neurotrophin receptor
(p75NTR), which was localized to the PM (Fig. 4A,B), and
by co-localization with an ER marker, PDI (Fig. 4C,D). A
similar localization was obtained in HEK-293 cells and in
NIH-3T3 ¢broblasts (not shown). Finally, we examined
whether enzyme AJ222801 is translocated to the PM upon
activation of the SM signalling pathway. No di¡erence in
the intracellular localization of C-GFP^AJ222801 was de-
tected when 3T3 cells were co-transfected with p75NTR in
the absence or presence of nerve growth factor (data not
shown), a natural ligand of p75NTR that activates SM signal-
ling [6,7].
Fig. 1. Putative topology of enzyme AJ222801. The upper scheme
shows the topology as originally suggested [2], and the lower scheme
shows a topology prediction based on three other prediction pro-
grams that each give essentially the same result. Note that neither
of these schemes speci¢es the orientation of the protein with respect
to the inner or outer lea£et of the membrane bilayer.
Fig. 2. Distribution of enzyme AJ222801 in COS cells. COS cells
were transfected with C-GFP^AJ222801 (A, B), C-HA^AJ222801
(C, D), or N-HA^AJ222801 (E, F). The left-hand panels are phase
contrast micrographs, and the right-hand panels are immuno£uores-
cence micrographs. Bar = 20 Wm.
Fig. 3. Distribution of A346-HA^AJ222801 in COS cells. Cells were
transfected with A346-HA^AJ222801 and localization was analyzed
in permeabilized (A, B) and non-permeabilized (C, D) cells. The
left-hand panels are phase contrast micrographs, and the right-hand
panels are immuno£uorescence micrographs. Bar = 20 Wm.
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4. Discussion
In the current study, we have demonstrated that enzyme
AJ222801, originally suggested to be a N-SMase, is localized
to the ER in a variety of cultured cells. This conclusion is
di¡erent from that reached by Tomiuk et al. [2], who sug-
gested that the protein is located at the PM. However, this
conclusion was based solely on cell fractionation experiments,
in which a PM-enriched fraction was obtained by centrifuga-
tion at 2500Ug. Clearly, the PM cannot be resolved from
other membrane fractions by such low-speed fractionation.
Interestingly, amino acid residues 405^413 of the mouse ho-
molog of enzyme AJ222801 (EPHLAYCL) are 75% identical
to residues 78^85 (EPYLFYCL) of human UDP-glucurono-
syltransferase (UGT1A6). This sequence is part of a domain
that acts as an internal signal retention sequence and an ER-
targeting domain for UDP-glucuronosyltransferase [8].
Our data are also consistent with the recent suggestion that
the natural substrate for enzyme AJ222801 is lyso-PAF, not
SM, since little if any SM is believed to be associated with the
ER [9]. PAF is deacylated to lyso-PAF by the activity of an
acetylhydrolase, and it is generally thought that the next steps
in the pathway of PAF inactivation are sequential degrada-
tion by a lyso-phospholipase D, yielding alkylglycerol phos-
phate, and a phosphohydrolase, to yield alkylglycerol [10]. A
lyso-PAF phospholipase C alleviates the need for two enzy-
matic steps to produce alkylglycerol. Further study will be
required to determine the role of this reaction in lipid metab-
olism and/or signalling in the ER.
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Fig. 4. Analysis of C-GFP^AJ222801 localization by comparison
with PM and ER markers. COS cells were transfected with C-GFP^
AJ222801 (A) and p75NTR (B); note the complete lack of overlap
of immuno£uorescence labeling. The localization of PDI (D) was
compared with that of C-GFP^AJ222801 (C); note that these two
proteins display identical intracellular localizations in the transfected
cells. Bar = 20 Wm.
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